Your browser doesn't support javascript.
loading
De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor.
Morel, Adeline; Masliah-Planchon, Julien; Bataillon, Guillaume; Becette, Véronique; Morel, Claire; Antonio, Samantha; Girard, Elodie; Bièche, Ivan; Le Tourneau, Christophe; Kamal, Maud.
Affiliation
  • Morel A; Institut Curie, PSL Research University, Paris, France.
  • Masliah-Planchon J; Institut Curie, PSL Research University, Paris, France.
  • Bataillon G; Institut Curie, PSL Research University, Paris & Saint-Cloud, France.
  • Becette V; Institut Curie, PSL Research University, Paris & Saint-Cloud, France.
  • Morel C; Institut Curie, Paris & Saint-Cloud, France.
  • Antonio S; Institut Curie, PSL Research University, Paris, France.
  • Girard E; INSERM U900, Institut Curie, Saint-Cloud, France.
  • Bièche I; Institut Curie, PSL Research University, Paris, France.
  • Le Tourneau C; INSERM U1016, Paris Descartes University, Paris, France.
  • Kamal M; Institut Curie, Paris & Saint-Cloud, France.
Article in En | MEDLINE | ID: mdl-32914015

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JCO Precis Oncol Year: 2019 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JCO Precis Oncol Year: 2019 Document type: Article Affiliation country: France Country of publication: United States